Letter to the Editor
By submitting a letter, you are giving CAP TODAY permission to publish an edited version of that letter in the “Letters” column. You will be notified prior to publication if CAP TODAY elects to run your letter.
Wednesday, July 15, 2026, 1:00-2:00 PM ET
Hear an expert discuss how to integrate Kappa and Lambda in situ hybridization testing into your standard hematopathology workflow to accurately assess B-cell and plasma cell clonality. You will also gain the skills to recognize testing pitfalls in challenging reactive versus neoplastic proliferations and apply ancillary tools to resolve complex cases.
Webinar presenter Xiaojun Wu, MD, PhD, Assistant professor, Director of Hematopathology Section at NCR of Johns Hopkins Medicine Department of Pathology, SOM at Johns Hopkins University
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, July 21, 2026, 11:00-11:30 AM CT
Roundtable presenters Nick Fingland, PhD, PMP, Senior Director, R&D Operations and Science, BD, and Chris Farnsworth, PhD, D(ABCC), Section Head of Clinical Chemistry, Professor of Pathology and Immunology, Washington University School of Medicine.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
By submitting a letter, you are giving CAP TODAY permission to publish an edited version of that letter in the “Letters” column. You will be notified prior to publication if CAP TODAY elects to run your letter.
CAP TODAY looks for interview sources with stories to tell that will be of use to other labs. If we decide to report on your lab’s story, a writer will request a phone interview. CAP TODAY will acknowledge receipt of all emails.